Bringing the fundamentals into focus…
Back to Theravance Biopharma Inc
How Theravance Biopharma Inc stacks up
TBPH · against 442 other Healthcare companies of similar size
Growth
94/ 100
Near the top of its peers.
Ranked #20 of 443 · scores higher than 95% of peers
Bars: peers in each 10-point band of the growth score38 peers with a growth score of 90–100, including TBPH · Click a bar to see the companies
Why growth scores 94?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over three years: stronger than 86% of peers. 3-year revenue growth: 26.7% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 87% of peers. Revenue growth: 35.1% vs peer median 6.1%
- faster growth in earnings per share: stronger than 95% of peers. Earnings per share growth: 300.5% vs peer median 9.8%
Metric by metric
Position: dot = TBPH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TBPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 451 reported | 35.1% | 4.1% | 91% | 33% | |
| Earnings per share growthHigher is better · 240 reported | 300.5% | 4.8% | 96% | 33% | |
| 3-year revenue growthHigher is better · 437 reported | 26.7% | 4.9% | 87% | 33% |
Ranking by growth score
Top 5 and the companies ranked around TBPH| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 15 | 1.3B USD | 95 | 33 | |
| 15 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score